Chris Newmarker
Executive Editor, Life Sciences at MassDevice
Executive Editor, Life Sciences at Medical Design & Outsourcing
Executive Editor, Life Sciences at Pharmaceutical Processing World
Executive Editor, Life Sciences at Drug Discovery & Development
Executive Editor, Life Sciences at Medical Tubing + Extrusion
A journalist for over 20 years, I am executive editor of Life Sciences at WTWH Media. Media outlets include MassDevice, Medical Design & Outsourcing and more.
Articles
-
1 day ago |
massdevice.com | Chris Newmarker
AdvaMed CEO Scott Whitaker appeared before the U.S. Senate Finance Committee today to continue to assert that medtech deserves tariff exemptions in trade negotiations. “To be clear, we applaud the president’s efforts to bring more manufacturing back the United States and fix some of the existing trade imbalances, but the reality is, up to 70% of medtech used in America is already made in America, supporting 3 million jobs across this country, and that’s growing every day.
-
2 days ago |
massdevice.com | Chris Newmarker
Paragonix Technologies announced today that its LiverGuard System successfully preserved a donor liver transported from the West Coast to a transplant performed at Duke University Hospital in North Carolina. Waltham, Massachusetts–based Paragonix, which Swedish medtech company Getinge acquired for $477 million in 2024, said the case marks one of the longest liver procurements on record, utilizing the company’s advanced hypothermic preservation.
-
3 days ago |
therobotreport.com | Chris Newmarker
SS Innovations plans to submit a de novo classification request to the U.S. FDA for its SSi Mantra 3 surgical robotic system. Fort Lauderdale, Florida-based SS Innovations plans to submit in July. The submission will include an application for multi-specialty indications, including urology, gynecology, general surgery, and thoracic and cardiac surgery. The SSI Mantra 3 system features a modular, open-console design with 3D visualization and enhanced ergonomics.
-
6 days ago |
massdevice.com | Chris Newmarker
Globus Medical (NYSE: GMED) stock is down today on an unexpectedly soft start to the year amid an earlier-than-planned integration with recently acquired Nevro. GMED shares were down more than 22% this morning to $56.51 apiece, the day after the spine treatment tech company released an after-hours Q1 earnings report that missed The Street. [Find out more about Globus Medical and other major orthopedic device companies in our Orthopedic Device Companies Special Report.
-
1 week ago |
massdevice.com | Chris Newmarker
SS Innovations announced today that it plans to submit a de novo classification request to the U.S. FDA for its SSi Mantra 3 surgical robotic system. Fort Lauderdale, Florida-based SS Innovations plans to submit in July. The submission will include an application for multispecialty indications, including urology, gynecology, general surgery, and thoracic and cardiac surgery. The SSI Mantra 3 system features a modular, open-console design with 3D visualization and enhanced ergonomics.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 2K
- Tweets
- 6K
- DMs Open
- No
According to Outset Medical, Inc., the FDA’s warning letter does not request the restriction of Tablo’s manufacturing, production or shipment in the U.S. It also does not request the withdrawal of the system from the U.S. market. S…https://t.co/MLauvwVNZR https://t.co/NJdmv6kHiU
#Medtech #meddevice industry #mergersandacquisitions continue. This time, Coloplast is buying. https://t.co/XgjNYEgaqZ
This move marks the second software-related buy in the past year for ResMed. #medtech #mergersandacquisitions #digitalhealth #sleepapnea #cpap https://t.co/p1UljWrAAL